Stock Analysis on Net

Allergan Inc. (NYSE:AGN.)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 19, 2015.

Analysis of Debt

Microsoft Excel

Paying users area

The data is hidden behind: . Unhide it.

  • Get 1-month access to Allergan Inc. for $22.49, or

  • get full access to the entire website for at least 3 months from $62.19.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Total Debt (Carrying Amount)

Allergan Inc., balance sheet: debt

US$ in thousands

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Notes payable
Convertible notes
Long-term debt, excluding current maturities
Total notes payable and long-term debt (carrying amount)

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).

Debt item Description The company
Total notes payable and long-term debt (carrying amount) Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. Allergan Inc. total debt increased from 2012 to 2013 and from 2013 to 2014.

Total Debt (Fair Value)

Microsoft Excel
Dec 31, 2014
Selected Financial Data (US$ in thousands)
Notes payable
Convertible notes
Long-term debt
Total notes payable and long-term debt (fair value)
Financial Ratio
Debt, fair value to carrying amount ratio

Based on: 10-K (reporting date: 2014-12-31).


Weighted-average Interest Rate on Debt

Weighted-average effective interest rate on debt:

Interest rate Debt amount1 Interest rate × Debt amount Weighted-average interest rate2
Total

Based on: 10-K (reporting date: 2014-12-31).

1 US$ in thousands

2 Weighted-average interest rate = 100 × ÷ =


Interest Costs Incurred

Allergan Inc., interest costs incurred

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Interest expense
Interest capitalized
Interest costs incurred

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).

Debt item Description The company
Interest expense Amount of the cost of borrowed funds accounted for as interest expense for debt. Allergan Inc. interest expense increased from 2012 to 2013 but then slightly decreased from 2013 to 2014.
Interest capitalized Amount of interest costs capitalized disclosed as an adjusting item to interest costs incurred. Allergan Inc. interest capitalized increased from 2012 to 2013 and from 2013 to 2014.
Interest costs incurred Total interest costs incurred during the period and either capitalized or charged against earnings. Allergan Inc. interest costs incurred increased from 2012 to 2013 but then slightly decreased from 2013 to 2014.

Adjusted Interest Coverage Ratio

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Selected Financial Data (US$ in thousands)
Net earnings attributable to Allergan, Inc.
Add: Net income attributable to noncontrolling interest
Less: Discontinued operations
Add: Income tax expense
Add: Interest expense
Earnings before interest and tax (EBIT)
 
Interest costs incurred
Financial Ratio With and Without Capitalized Interest
Interest coverage ratio (without capitalized interest)1
Adjusted interest coverage ratio (with capitalized interest)2

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).

2014 Calculations

1 Interest coverage ratio (without capitalized interest) = EBIT ÷ Interest expense
= ÷ =

2 Adjusted interest coverage ratio (with capitalized interest) = EBIT ÷ Interest costs incurred
= ÷ =


Solvency ratio Description The company
Adjusted interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments (including capitalized interest). Allergan Inc. adjusted interest coverage ratio deteriorated from 2012 to 2013 but then improved from 2013 to 2014 exceeding 2012 level.